10 Best GLP-1 Programs of 2026 (Support & Price Compared)

Most rankings of the best GLP-1 programs just compare drug prices. This one compares the program — the coaching, the app, the clinician check-ins, and the human support that shows up after the vial does. That is where these 10 telehealth platforms actually differ, and where a cheap plan can quietly turn expensive.

One note before the countdown. Ro holds our highest overall score (8.8), but Noom Med (8.7) takes the #1 slot on this page. Judged purely as a program — curriculum, coaching, food logging, structured check-ins — Noom’s stack is the deepest we have documented. A pure medication ranking would flip them. Program fees across this list run from $99 to $449 a month, so read each Pricing Structure section closely.

1. Noom Med — the only true coaching-first program

Score: 8.7/10 (Very Good). Noom Med is the prescribing arm of Noom, the psychology-based weight app running since 2008. Every medication plan — compounded or brand-name — includes the full Noom app, 1:1 coaching, and a behavior-change curriculum at no extra charge. No other program on this list bundles that much non-drug support as standard.

The medication side is flexible too. Noom sells compounded semaglutide and tirzepatide plans, a lower-priced microdose tier, and a $39-to-start telehealth plan for brand-name Wegovy, Ozempic, Zepbound, or Mounjaro through your insurance. Be clear on one thing: compounded semaglutide and tirzepatide are not FDA-approved, and Noom’s own disclaimer says so.

Pricing Structure

Plan	First month	Then
Microdose GLP-1Rx	$79	$179-$199/mo
GLP-1Rx (compounded semaglutide)	$129	$249-$279/mo
GLP-1Rx Plus (compounded tirzepatide)	$149	$299/mo
Brand-name telehealth plan	$39	$99/mo + drug cost

Billing is quarterly after month one — lump sums of $537 to $837 per 12 weeks depending on plan. Here is the fine print we flagged: in July 2026, Noom’s pricing hub and its own product pages showed different recurring rates ($249 vs $279 for semaglutide). That gap is real money over a year.

Pros & Cons

Pros:

• Coaching, app, and curriculum included with every plan — the deepest program stack here
• Low entry pricing: $79, $129, or $149 first month depending on tier
• Taper-Off Guarantee announced in 2024: free Noom or medication discounts if weight returns within 18 months after the taper protocol
• BBB rating A+, accredited since 2021

Cons:

• Compounded plans are not available in Alabama, Louisiana, or Mississippi
• Price jumps sharply after the promo month — $79 can become $199/mo
• No published refund policy beyond cancel anytime
• Brand plan excludes the drug itself, which can top $1,000/mo without coverage

2. Ro — the strongest medical support system

Score: 8.8/10 (Very Good). Ro is our highest-scored provider overall, and its program muscle is medical rather than behavioral. Members get 24/7 care-team access, unlimited provider messaging, structured check-ins, dose titration support — and the best insurance machinery in telehealth. Ro’s concierge checks your coverage free and files prior-authorization paperwork for you.

Ro sells only FDA-approved, brand-name GLP-1s as of July 2026: Wegovy pen and pill, Zepbound, the new Foundayo pill, and off-label Ozempic. No compounded drugs appear on its pricing page. It ranks #2 here only because coaching is lighter than Noom’s curriculum — as medicine-plus-logistics, it is the one to beat.

Pricing Structure

Membership costs $39 the first month, then $149/month — or as low as $74/month prepaid annually. Medication is always billed separately. Cash prices: Wegovy pill and Foundayo pill $149 the first month, then $199-$299; Wegovy pen $199, then $199-$399; Zepbound KwikPen $299, then $399-$449. Ro’s FAQ confirms Wegovy’s price rises at higher doses.

With insurance, the drug may cost only a copay. Without it, off-label Ozempic runs $900-$1,100/month at the pharmacy. Ro says its cash prices match LillyDirect, NovoCare, and TrumpRx.

Pros & Cons

Pros:

• 100% FDA-approved brand-name menu sourced through official Novo Nordisk and Eli Lilly channels
• Insurance concierge handles prior authorizations; approval decisions in about 2 days
• Serves all 50 states plus D.C.; membership charged only if you qualify
• First on telehealth with the Wegovy pill in January 2026

Cons:

• $149/month membership stacks on top of every drug bill
• Medication price climbs with dose — Zepbound reaches $449/month
• Trustpilot around 3.7/5 with 610 BBB complaints, per its BBB profile
• Requires a healthcare visit within the past 3 years to qualify

3. Hers — fast async care with real app tools

Score: 8.5/10 (Very Good). Hers is the women’s brand of NYSE-listed Hims & Hers, serving all 50 states. The program is built for speed: complete an intake, and a licensed provider typically reviews it within 24 hours — no video visit in most states, no lab work. Membership includes 24/7 provider messaging, check-ins for dose titration, and app-based coaching tools.

The catch is history. The FDA sent Hers a warning letter on September 9, 2025 over false or misleading marketing of compounded semaglutide, which is not FDA-approved. By mid-2026, Hers had pivoted to brand-name drugs, with compounded product limited to medical necessity per third-party reporting.

Pricing Structure

Membership runs $39 the first month, then $149/month, auto-renewing and billed separately — and per the official site, it does not include or guarantee a prescription. Medication is cash-pay only: Wegovy pill, Ozempic pill, and Foundayo pill from $149/month; Wegovy pen and Ozempic from $199; Zepbound formats from $299. Retail Mounjaro and Zepbound are listed at $1,899/month for contrast.

Those are from prices. Cost can rise with dose, and Hers does not publish full dose-by-dose pricing. Cheapest realistic first month is about $193 including $5 shipping, then roughly $303/month ongoing, per third-party pricing reports.

Pros & Cons

Pros:

• Provider review typically within 24 hours; asynchronous from start to finish
• Brand-name GLP-1s at $149-$299/month cash — far under the $1,899 retail listings on its own page
• Pill and injectable options; BBB rating A+ with roughly 3.8/5 across about 7,000 reviews per third-party reporting
• 24/7 messaging and app coaching tools included in membership

Cons:

• Insurance not accepted anywhere — everything is out of pocket
• Refund window is 48 hours on unshipped initial orders; canceling meds does not cancel the membership
• Sept 2025 FDA warning letter and a Feb 2026 Novo Nordisk patent lawsuit
• Reviewers report shipping hiccups and hard-to-cancel subscriptions

4. bmiMD — the budget program that still answers messages

Score: 8.2/10 (Very Good). bmiMD proves cheap does not have to mean abandoned. Its flat monthly price bundles a same-day telehealth visit, unlimited provider messaging, monthly check-ins, and refill management. The card is only authorized — not charged — until a provider approves you, and you get a 100% release of the hold if you are ineligible.

The menu is compounded-only: semaglutide and tirzepatide, standard or microdose. No brand-name Wegovy, Zepbound, or Ozempic option exists here, and bmiMD’s site plainly discloses its compounded drugs are not FDA-approved. It publishes third-party quality-testing claims — potency within plus-or-minus 10%, USP 797 sterility — which most budget rivals skip.

Pricing Structure

Compounded semaglutide: $99/month on the 12-month plan (billed $1,188 upfront), $109 on 6-month, $119 on 3-month, or $129 month-to-month. Compounded tirzepatide runs $139-$159/month, with an $89.50 first-month promo for new members. The price is the same at every dose, and shipping is free on subscriptions.

Watch the billing mechanics. Long plans charge the full period at once, and a $50 non-refundable cancellation fee applies if you cancel between intake approval and pharmacy processing. Once the pharmacy processes your order, all sales are final.

Pros & Cons

Pros:

• Flat price at every dose — no titration surprises
• All-in $99-$129/month with unlimited messaging; no membership fee
• HSA/FSA accepted, buy-now-pay-later offered, 3-5 day shipping
• Trustpilot around 4 stars across roughly 800+ reviews, per July 2026 snapshots

Cons:

• BBB rating C+, not accredited, 38 complaints on file
• No refunds on partially used subscription periods
• Compounding pharmacy partners are not named
• Cheapest rate demands a $1,188 upfront commitment

5. TrimRx — everything in the box, including the sharps container

Score: 7.8/10 (Good). TrimRx sells the most literal version of all-inclusive on this list. The advertised price covers provider consultations, a 4-5 week medication supply, syringes, alcohol pads, a sharps container, cold-chain shipping, and monthly check-ins with dose adjustments. Per third-party review, $0 is charged until a prescription is actually approved.

Its core products are compounded semaglutide and tirzepatide, which are not FDA-approved; brand-name drugs are available at $1,299-$1,399/month per its March 2026 press release. The company itself is young — founded June 2024 — and its paper trail shows it.

Pricing Structure

Compounded semaglutide starts at $199/month with an annual commitment; standard month-to-month pricing is about $349, per the company’s press release. Compounded tirzepatide is advertised at $349/month flat across all doses from 2.5 to 15 mg ($449 standard). Third-party reports show 12-month prepay tiers as low as $174/month for semaglutide.

The problem is consistency. TrimRx’s own blog quotes tirzepatide at $299, $349, and $449 in different posts. When a provider cannot keep its own numbers straight, budget for the higher figure.

Pros & Cons

Pros:

• Genuinely all-inclusive: supplies, cold-chain shipping, consults, and check-ins in one price
• Flat tirzepatide pricing across the full dose range — rare in this market
• $0 due until approval; HSA/FSA accepted
• BBB accredited since June 2025

Cons:

• Headline $199 requires a 12-month commitment paid up front
• Trustpilot around 3.3/5 across roughly 727 reviews, heavily polarized
• No refunds reported for unused prepaid months
• Pharmacy partners unnamed; BBB profile currently under review with no rating

6. MEDVi — flat refills and a 14,000-review paradox

Score: 7.6/10 (Good). MEDVi bundles provider review, medication, free expedited shipping, and unlimited telehealth support into one monthly price, with prescriptions issued by independent clinicians through OpenLoop Health — most reviews inside 24 hours. It is one of the few platforms selling both weekly injections and daily dissolvable tablets of semaglutide and tirzepatide, none of which are FDA-approved in compounded form.

Its reputation splits down the middle. Trustpilot shows about 4.4/5 across roughly 14,000 reviews, yet the BBB assigns MEDVi an F rating with 662 complaints — 100 of them unanswered. Recurring complaint themes: surprise auto-renewal charges, often $399, and cancellation friction.

Pricing Structure

Compounded semaglutide injections cost $179 the first month, then $299/month on refills — a 67% jump after the promo, confirmed in MEDVi’s own January 2026 press release. The refill price stays flat as your dose rises. Semaglutide tablets start at $249; tirzepatide starts at $349, with refills of $399-$499 reported by third-party pricing reports but not published by MEDVi.

Brand-name plans work differently: a $99 membership plus medication cost, with Ozempic listed at $1,999/month. One review site reports 28-day billing cycles — about 13 charges a year, not 12.

Pros & Cons

Pros:

• No membership fee on compounded plans; support and shipping bundled
• Flat $299 semaglutide refills regardless of dose
• Names its compounding pharmacies — Triad Rx, RedRock, Beaker — unlike most rivals
• Injection and tablet formats both offered

Cons:

• BBB rating F with 662 complaints is the worst enforcement-adjacent record in our top 6
• Tirzepatide and tablet refill prices are not published
• Refunds generally unavailable once a cycle’s medication is dispensed
• 49-state coverage, and some states require an extra live visit

7. ReadyRx — the only program that refunds you for not losing weight

Score: 7.2/10 (Good). ReadyRx runs a lean, message-based program: a 2-minute intake, board-certified clinician review usually within 24 hours, and unlimited provider messaging bundled free. Its signature is the guarantee — a full refund if you lose less than 5% of your body weight after 28 weeks of documented adherence. Nobody else on this list puts a number on outcomes like that.

The trade-offs are transparency and reach. The official site hides every price behind signup, showing placeholder text instead of dollars. Compounded semaglutide skips 7 states, and tirzepatide additionally skips California and North Carolina. Its compounded drugs are not FDA-approved, which the site states outright.

Pricing Structure

Per third-party pricing reports, compounded semaglutide costs $299/month month-to-month, or $249/month with a $747 three-month prepay. Compounded tirzepatide is $399/month with no multi-month discount. Pricing is flat across doses, and occasional first-month promos have reportedly dipped as low as $19.

There is no membership fee. Consults, unlimited messaging, and expedited cold shipping are baked into the medication price. Just know the guarantee clock is long: 28 weeks of adherence before a refund claim qualifies.

Pros & Cons

Pros:

• 5%-in-28-weeks money-back guarantee — unique on this list
• No platform fee; approval commonly within 24 hours, delivery in 3-5 days
• LegitScript certified, with third-party lab testing and certificates of analysis
• Trustpilot 4.7-4.8/5, though on a small base of about 65 reviews

Cons:

• Zero prices published on the official site
• Text-only support — no video or phone consults, ever
• Missing from up to 9 states depending on the drug
• Not BBB accredited, with a thin overall track record

8. OMZO — fast shipping, thin paper trail

Score: 6.9/10 (Fair). OMZO wraps consultation, prescription, medication, shipping, and app-based care-team messaging into one monthly bundle, and moves fast: medication ships within 48 business hours of approval, arriving in 3-5 business days. You get a full refund if a clinician finds you ineligible, and a stated refund right if nothing ships within 14 business days.

The program itself is serviceable. The company behind it is the question mark. OMZO’s terms name no legal entity and no physical business address, its pharmacy partners are unnamed, and its compounded semaglutide and tirzepatide are not FDA-approved — the site’s own footer says the FDA has not reviewed them for safety, effectiveness, or quality.

Pricing Structure

Per OMZO’s terms, compounded semaglutide costs $199 the first month, then $299/month; the funnel page still advertises $179, an unexplained $20 gap. Compounded tirzepatide runs $349 the first month, then $399/month. Oral GLP-1 tablets start at $249. Brand-name Ozempic appears at $1,299/month in the terms but $1,999/month in the site navigation — another contradiction.

Refunds outside ineligibility are narrow: billing errors only, requested within 28 days, by email. The funnel’s money-back guarantee language does not match the actual terms. Trust the terms.

Pros & Cons

Pros:

• One bundled price with free shipping, no contract, and no membership fee
• Semaglutide refills locked at $299 with no dose-based tiers
• Injectable, oral tablet, tirzepatide, and brand-name paths all exist
• 48-business-hour shipping after approval is among the fastest claimed here

Cons:

• About 7 Trustpilot reviews total and no BBB profile — a nearly blank reputation
• Pricing contradicts itself across the site ($179 vs $199; $1,299 vs $1,999)
• Orders become non-refundable once you submit the medical intake
• No named legal entity, address, or pharmacy partners

9. Trinity Meds — tempting prices, troubling record

Score: 6.8/10 (Fair). Trinity Meds posts some of the lowest sticker prices in telehealth and names all four of its dispensing pharmacies — Belmar, Strive, Epiq Scripts, and Casa Pharma Rx — which beats most competitors for supply-chain transparency. The advertised price includes the consult, prescription, shipping, and check-ins, with same price, every dose stated on the official site.

Then the record intrudes. Trustpilot sits at 2.1/5 from 119 reviews, 65% one-star, with complaints about charges after cancellation. And in June 2026, the FDA issued a warning letter to Trinity Healthcare Supply, LLC — the same legal entity Trinity Meds names in its own press materials — over misleading compounded GLP-1 claims on its affiliated altRx brand site. Its compounded semaglutide and tirzepatide are not FDA-approved.

Pricing Structure

Drug	Monthly	12-month plan
Compounded semaglutide	$99/mo	$84/mo
Compounded tirzepatide	$149/mo	$125/mo
Brand Ozempic (funnel)	from $999/mo	—

One problem: Trinity’s own funnel page lists semaglutide from $159/month and tirzepatide from $259/month — up to 74% above the main site’s numbers. The company’s terms also say consult fees are non-refundable, all prescription sales are final, and every program auto-renews until you explicitly cancel.

Pros & Cons

Pros:

• $99/month semaglutide is the lowest monthly headline price on this list
• Four pharmacy partners publicly named with contact details
• Flat pricing at every dose; FSA-eligible with buy-now-pay-later options
• $100-off first-order promo with free tracked shipping

Cons:

• Trustpilot 2.1/5 with 65% one-star reviews and unanswered complaints
• June 2026 FDA warning letter to its parent LLC (altRx brand)
• Its own pages disagree on price by $60-$110/month
• All-sales-final terms plus auto-renewal is a rough combination

10. Sprout Health — a price lock buried under red flags

Score: 6.4/10 (Fair). Sprout Health makes one genuinely good promise: your monthly price never increases, even if your dosage increases — stated explicitly on its site. It bundles clinician review, medication, shipping, and ongoing oversight with no membership fee, offers a sublingual no-needle semaglutide option, and refunds you if the clinician rules you ineligible.

Everything around that promise is a warning sign. The FDA sent Sprout a warning letter on September 9, 2025 for falsely claiming its compounded GLP-1s were FDA-approved — they are not, and no compounded GLP-1 is. The BBB rates it F with 63 complaints, 32 unanswered. Trustpilot shows about 2.2/5 with 84% one-star, per July 2026 search snapshots. The company only began operating in January 2025.

Pricing Structure

The homepage advertises compounded semaglutide from $149/month and compounded tirzepatide from $199 (regular $349). The semaglutide page lists a 3-month supply at a $465 promo, regular $615 — about $155/month while the promo lasts. Brand-name Wegovy and Zepbound are offered at $1,799 and $1,999/month.

Displayed prices are promotional and shift over time; third-party reports cite older figures of $199-$299/month. Once medication ships, it cannot be returned, and the subscription auto-refills until canceled.

Pros & Cons

Pros:

• Explicit price-lock guarantee across dose increases
• No membership or consult fees; delivery generally 5-7 business days
• Sublingual semaglutide option for the needle-averse
• Refund if the clinician determines you are ineligible

Cons:

• Sept 2025 FDA warning letter for the exact claim buyers care most about
• BBB rating F and about 2.2/5 on Trustpilot with 84% one-star
• BBB complaints report charges within minutes of applying, before any consult
• No shipping to Arkansas, Kansas, or New Mexico; pharmacies unnamed

What the Best GLP-1 Programs Include Beyond the Drug

Four things, minimum. A licensed prescriber who re-evaluates you at each dose change. A stated check-in cadence — monthly at bmiMD and TrimRx, on-demand at most others. A real messaging channel with response times. And transparent billing you can cancel without a fight. Our how we rank page weighs each of these against price and complaint records.

Membership math matters as much as drug price. Ro and Hers charge $149/month for the program alone after the first $39 month — that is $1,788 a year before any medication. Flat-bundle programs like bmiMD ($99-$129/month) fold everything into one number. Neither model is automatically better; the bundled ones just fail louder when support goes dark, as F-rated BBB records here show.

Also confirm which molecule you are actually buying. Brand-name Wegovy and Zepbound are FDA-approved for chronic weight management; compounded semaglutide and tirzepatide are not FDA-approved, full stop. Our GLP-1 drug list breaks down every option by molecule, format, and approval status.

How Fast Do GLP-1 Programs Show Results?

Slower than the ads suggest, because dosing ramps gradually. In the STEP 1 trial, adults on semaglutide 2.4 mg lost an average of about 14.9% of body weight over 68 weeks — roughly 16 months. In SURMOUNT-1, tirzepatide produced up to about 20.9% average loss at 72 weeks on the highest dose. Both figures include diet and activity support alongside the drug.

That timeline is why program quality matters. Titration takes months, side effects peak early, and dropouts cluster in weeks 4-12 — exactly when coaching and quick clinician responses earn their fee. See our guide on how fast GLP-1s work for a month-by-month picture. Any program promising a specific number of pounds by a specific date is marketing, not medicine.

Can You Use a GLP-1 Program for Diabetes Instead of Weight Loss?

These programs are weight-loss services, not diabetes care. Ozempic and Mounjaro carry FDA approval for type 2 diabetes; Wegovy and Zepbound carry the weight-management approvals. When Ro or Hers lists Ozempic for weight loss, that is off-label prescribing — legal, common, and expensive without coverage at $900-$1,100/month cash per Ro’s own pricing page.

If you have diabetes, your insurance route usually beats every cash program here, because diabetes-labeled GLP-1s are far more likely to be covered. That is where Ro’s prior-authorization concierge earns its $149/month. Our guide to GLP-1 for diabetes vs. weight loss maps which label applies to which drug and what that means for coverage.

How Do You Spot a Weak GLP-1 Program?

Start with enforcement records. Two providers on this list — Hers and Sprout Health — drew FDA warning letters in September 2025 over compounded GLP-1 marketing, and Trinity Meds’ parent LLC received one in June 2026. The FDA issued more than 55 such letters to compounded GLP-1 sellers in that wave. A letter is not a shutdown, but it tells you how the company markets when it thinks nobody official is reading.

Then check the money mechanics. Red flags we found while building this ranking: prices hidden behind signup (ReadyRx), a company’s own pages disagreeing by $60-$110/month (Trinity Meds, OMZO), all-sales-final terms stacked on auto-renewal, and BBB grades of F with dozens of unanswered complaints (MEDVi, Sprout Health). The best GLP-1 programs of 2026 publish one price, honor one cancellation click, and answer their complaint file. Hold every contender to that bar — including our top picks.